PGP and acute lymphoblastic leukemia: Although in vivo combination activities of nilotinib and verapamil with DNR were not directly tested, these findings strongly suggest that overexpression of P‐gp is involved at least partly in resistance to VCR and DNR of P‐gp‐positive t(17;19)‐ALL cell lines.